LXEO
USDLexeo Therapeutics Inc. Common Stock
$8.190-0.110 (-1.325%)
실시간 가격
Healthcare
생명공학
미국
가격 차트
Loading Chart...
핵심 지표
시장 지표
시가
$8.300
고가
$8.355
저가
$7.660
거래량
2.85M
기업 기본 정보
시가총액
597.8M
산업
생명공학
국가
United States
거래 통계
평균 거래량
1.04M
거래소
NGM
통화
USD
52주 범위
저가 $1.45현재가 $8.190고가 $11.72
관련 뉴스
PR Newswire
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
Equity InsiderNews Commentary – Conventional small molecule approaches have struggled to address genetic defects and complex disease mechanisms,...
더 보기
Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Lexeo Therapeutics, Lowers Price Target to $13
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Lexeo Therapeutics with a Buy and lowers the price target from $15 to $13.
더 보기
Analyst Upgrades
Chardan Capital Maintains Buy on Lexeo Therapeutics, Raises Price Target to $17
Chardan Capital analyst Geulah Livshits maintains Lexeo Therapeutics with a Buy and raises the price target from $15 to $17.
더 보기
GlobeNewswire
Lexeo Therapeutics Announces Progress in FDA Discussions for Accelerated Approval Pathway and Positive Interim Clinical Data for LX2006 in Friedreich Ataxia Cardiomyopathy
U.S. Food and Drug Administration (FDA) open to pooling data from ongoing Phase I/II studies of LX2006 with pivotal data to support a Biologics License Application (BLA) for Accelerated Approval Interim clinical data
더 보기
